MSB 3.19% 97.0¢ mesoblast limited

Ann: Rexlemestrocel Greatest Benefit in Diabetics and Ischemics, page-272

  1. 208 Posts.
    lightbulb Created with Sketch. 133
    If mesoblast history is anything to go by, I have a feeling that this week we will receive FDA/OTAT minutes advising that mesoblast is on the right track but needs to refine a few further issues with potency/manufacturing and another meeting will be held in 4-6 months time once this issue is sorted. I am hoping that by posting this, this won’t happen, but I don’t want my expectations let down yet again
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.030(3.19%)
Mkt cap ! $1.107B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $3.342M 3.477M

Buyers (Bids)

No. Vol. Price($)
4 33313 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 73982 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.